Prostate cancer — all decisions

The Board granted an effective date of January 27, 2012 for the award of Dependency and Indemnity Compensation (DIC) based on direct service connection for the Veteran's cause of death and eligibility for Dependency Education Assistance (DEA) under 38 U.S.C. Chapter 35.

The Veteran was granted a temporary total evaluation for service-connected erectile dysfunction associated with prostate cancer from December 6, 2018, to January 31, 2019.

The Board granted service connection for prostate cancer, finding that the Veteran's in-service exposure to contaminated water at Camp Lejeune was related to his diagnosed condition.

The Board denied an effective date prior to June 18, 2014, for the grant of service connection for scars, prostate surgery, anterior trunk and denied a disability rating in excess of 40 percent for the service-connected residuals of prostate cancer. However, it granted an effective date of June 18, 2014, but no earlier, for the grant of a TDIU due to service-connected disabilities.

The Board denied the veteran's claim for service connection for prostate cancer as there is no evidence of an in-service injury or event that may be etiologically related to the diagnosed condition.

The Board remands the matter for further evidentiary development, including a new VA examination and obtaining private treatment records.

The Board remands the issues of entitlement to service connection for post-traumatic stress disorder and prostate cancer for additional development.

The Board granted service connection for prostate cancer and erectile dysfunction with an effective date of May 18, 2010, based on the Veteran's presumed exposure to herbicide agents during his service in Vietnam.

The Board granted service connection for prostate cancer stage 4 and bone cancer as secondary to the prostate cancer, but remanded the claim for residuals of a head injury due to insufficient evidence.

The Board remands the claim for an increased rating for prostate cancer with prostatitis to correct a duty-to-assist error.

The Board denied service connection for prostate cancer with urinary incontinence, chronic obstructive pulmonary disease (COPD), aortic insufficiency, and urothelial carcinoma (bladder cancer) as the evidence did not support a nexus between these conditions and the Veteran's military service.

The Board denied the veteran's claims for an initial compensable rating for erectile dysfunction and residuals of prostate cancer, as well as an increased level of special monthly compensation based on loss of use of a creative organ. The veteran was also denied an earlier effective date prior to August 10, 2022.

The Board remands the claims for service connection for the Veteran's cause of death and entitlement to DIC benefits due to an inadequate medical opinion regarding the relationship between the Veteran's service-connected conditions and his death.

The Board granted service connection for coronary artery disease, diabetes mellitus, type II, prostate cancer, hypertension, erectile dysfunction as secondary to the service-connected conditions, and incontinence as secondary to the service-connected prostate cancer. The decision was based on the Veteran's presumed exposure to herbicide agents during his service near the Korean Demilitarized Zone.

The appeal regarding the proposed reduction of the evaluation of prostate cancer from 100 percent to 0 percent was dismissed as a matter of law because there has been no final decision effectuating such a reduction.

The Board remands the claims for service connection for various conditions, as a statement of the case has not yet been issued.

The Board remands the claims for service connection for prostate cancer and erectile dysfunction as secondary to prostate cancer for further evidentiary development, including obtaining an adequate medical opinion.

The Board denied the veteran's appeals for earlier effective dates for service connection and special monthly compensation, finding that the earliest allowable dates were July 15, 2023, for prostate cancer and October 24, 2023, for lung cancer.

The Board dismissed the Veteran's appeals for service connection for diabetes mellitus, prostate cancer, right lower extremity chronic pain, and left lower extremity chronic pain due to the claims being in the legacy system and not properly opting into the Appeals Modernization Act (AMA) system.

The Board remands the claims for service connection for prostate cancer, incontinence, and erectile dysfunction due to a pre-decisional duty to assist error regarding potential herbicide exposure.